| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |